SCHEMBL28319481

SCHEMBL28319481

CN1CCN(Cc2cncnc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.55
LMNA P02545 1/20 0.52
CHKA P35790 6/20 0.49
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 2/20 0.46
CA2 P00918 1/20 0.46
NCF1 P14598 1/20 0.46
PRMT6 Q96LA8 1/20 0.46
MAPT P10636 1/20 0.46
HDAC6 Q9UBN7 1/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNA4 P43681 1/20 0.42
NPC1 O15118 2/20 0.41
TP53 P04637 2/20 0.41
RAB9A P51151 2/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3172320 0.79 CHRNB2 (0.58) ALDH1A1KDM4ECHRNB2CHRNA4
SCHEMBL14566661 0.78 MC4R (0.53) MC4RLMNACHKAALDH1A1KDM4E
SCHEMBL13778529 0.78 MC4R (0.49) MC4RLMNACHKAALDH1A1KDM4E
SCHEMBL8306431 0.78 CHRNB2 (0.72) MC4RALDH1A1KDM4ECHRNB2CHRNA4
SCHEMBL20332426 0.77 LMNA (0.58) MC4RLMNACHKAALDH1A1KDM4E
SCHEMBL27030980 0.77 MC4R (0.52) MC4RLMNACHKAALDH1A1KDM4E
SCHEMBL12424471 0.77 JAK1 (0.45) ALDH1A1CHRNB2CHRNA4RAB9AHPGD
SCHEMBL15014582 0.77 ACHE (0.58) ALDH1A1KDM4ECHRNB2CHRNA4
SCHEMBL19490801 0.77 MC4R (0.56) MC4RLMNACHKAALDH1A1KDM4E
SCHEMBL112800 0.77 MC4R (0.47) MC4RLMNACHKAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023229380-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF 주식회사 엘지화학 2023-11-30 WO disclosed
CN-110234652-A Benzimidazole derivative and preparation method and application thereof 贝达药业股份有限公司 2019-09-13 CN disclosed